Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis

Immunomodulatory therapy for rheumatoid arthritis (RA) carries risk for infectious complications. Understanding the risks of different therapeutic options is essential for making treatment decisions and appropriately monitoring patients. This review examines data on the risks for serious infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Riley, Thomas R, George, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893655/
https://www.ncbi.nlm.nih.gov/pubmed/33597206
http://dx.doi.org/10.1136/rmdopen-2020-001235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893655/
https://www.ncbi.nlm.nih.gov/pubmed/33597206
http://dx.doi.org/10.1136/rmdopen-2020-001235

Ejemplares similares